DelveInsight launched a new report on Idiopathic Pulmonary Fibrosis (IPF) Market Insights, Epidemiology and Market Forecast 2030.
DelveInsight’s Idiopathic Pulmonary Fibrosis (IPF) Market Report 2030 delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of IPFs in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
Idiopathic Pulmonary Fibrosis (IPF) is a rare, chronic, progressive fibrosing interstitial pneumonia which is found to affect the middle-aged and older adults; and affects lung tissue (alveoli in particular) by either thickening, stiffening, or persistent and progressive scarring (fibrosis) which increases irreversibly over time.
If an individual has IPF, scarring affects the air sacs, limiting the amount of oxygen that gets into the blood. With less oxygen in the blood, one can get breathlessness from everyday activities, like walking. This group of lung disorders is also known as ‘Diffuse Parenchymal Lung Diseases,’ which is characterized by a broader umbrella of ‘Interstitial Lung Diseases (IDLs).
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/idiopathic-pulmonary-fibrosis-market
According to DelveInsight, the total number of prevalent cases of Idiopathic Pulmonary Fibrosis (IPF) in 7 MM was found to be 229,170, in the year 2017.
According to DelveInsight, the market of Idiopathic Pulmonary Fibrosis in 7MM was found to be USD 1,510.4 Million in 2017, and is expected to increase during the course of the study period (2017–2030).
Idiopathic Pulmonary Fibrosis Report Insights:
Click here and download free sample pages of the report.
Table of contents
1 Key Insights2 Executive Summary of Idiopathic Pulmonary Fibrosis (IPF)3 Idiopathic Pulmonary Fibrosis (IPF) Market Overview at a Glance4 Disease Background and Overview: Idiopathic Pulmonary Fibrosis (IPF)5 Case Reports6 Idiopathic Pulmonary Fibrosis (IPF) Epidemiology and Patient Population7 United States Epidemiology8 EU5 Epidemiology9 Japan Epidemiology10 Current Idiopathic Pulmonary Fibrosis (IPF) Treatment and Medical Practices11 Unmet needs12 Idiopathic Pulmonary Fibrosis (IPF) Marketed Drugs13 Idiopathic Pulmonary Fibrosis (IPF) Emerging Drugs14 Idiopathic Pulmonary Fibrosis (IPF) 7MM Market Analysis15 United States16 EU-5 countries: Market Outlook17 Japan Market Outlook18 Idiopathic Pulmonary Fibrosis (IPF) Market Drivers19 Idiopathic Pulmonary Fibrosis (IPF) Market Barriers20 SWOT Analysis21 Reimbursement and market access22 Appendix23 DelveInsight Capabilities24 Disclaimer25 About DelveInsight
Download free report: https://www.delveinsight.com/report-store/idiopathic-pulmonary-fibrosis-market
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/